Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Hepatitis A vaccine approved in Canada

Oct. 4, 1996

Roche and Gilead Sciences to copromote hepatitis treatment in the U.S.

Oct. 4, 1996

LeukoSite and Oxford Asymmetry collaboration in IBD

Oct. 4, 1996

Promising phase III results with treatment for ulcerative colitis

Oct. 4, 1996

Clinical trial on oral H. pylori vaccine completed

Oct. 4, 1996

GI drugs under development at Takeda

Sep. 27, 1996

First combined hepatitis A/B vaccine approved

Sep. 27, 1996

Prokinetic agents from Nisshin Flour Milling

Sep. 27, 1996

p65 antisense oligonucleotides for Crohn's disease

Sep. 27, 1996

Generic dicyclomine HCl now available in the U.S.

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026